News and Updates

Scientists in Germany have simplified the iPS (induced pluripotent stem) cell reprogramming procedure from four genes to one gene, though the choice of cell type plays an important role.

At last, for the first time, Geron offers an explanation for the FDA-imposed hold on its highly publicized human embryonic stem cell clinical trial.

Prosecutors in South Korea have recommended a four-year prison term for Hwang Woo-suk, whose fraudulent stem cell reports caused an international scandal.

The Olympic medalist Shannon Miller has signed a marketing endorsement partnership with StemCyte, one of the world’s leading cord blood banks.